Eduardo Angulo Elizari

Eduardo Angulo Elizari is a researcher affiliated with the Cancer Center Clínica Universidad de Navarra (CCUN) at the University of Navarra. His work focuses on the design and preclinical development of novel selenated derivatives with antitumor and antileishmanial potential.

• Institution: University of Navarra
• Research Group: SECALE (Selenated derivatives against cancer, trypanosomes, and other pathologies)

Research Focus: Utilizes organoselenium chemistry for translational applications in oncology and parasitic diseases. His thesis work concentrated on synthesizing and evaluating new selenoderivatives through preclinical pharmacology frameworks.

Academic Background: Earned his PhD under supervision of Dr. Daniel Plano Amatriain and Dr. María del Carmen Sanmartín Grijalba, with institutional affiliation to the University of Navarra's clinical cancer research infrastructure.